Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-4833 (SYR-322) oral therapy in diabetes
jRCT1080221871Phase 4
- Sponsor
- Takeda
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080221871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221871.